Ottawa, Ontario, Canada Canadian Institutes of Health Research appeared to be the Corporate Investor, which was created in 2000. The company was established in North America in Canada. The leading representative office of defined Corporate Investor is situated in the Ottawa.
Besides, a startup requires to be at the age of 11-15 years to receive the investment from the fund. For fund there is a match between the country of its foundation and the country of its the most frequent investments - Canada. We can highlight the next thriving fund investment areas, such as Medical, Therapeutics. Among the various public portfolio startups of the fund, we may underline ProMIS Neurosciences
This organization was formed by Patrick Neary.
The standard case for the fund is to invest in rounds with 1 partaker.
The usual things for fund are deals in the range of 100 thousands - 1 million dollars. The important activity for fund was in 2017. The top amount of exits for fund were in 2007. The fund is constantly included in less than 2 deals per year.
Related Funds
| Fund Name | Location |
| 500.com | China, Guangdong, Shenzhen |
| ABB | Switzerland, Zürich, Zurich |
| Amsterdam Venture Partners | Amsterdam, Noord-Holland, The Netherlands |
| Atlas Pacific Capital | California, San Jose, United States |
| Base 10 Web Solutions | Canada, Ontario, Ottawa |
| Co-Investor | Switzerland, Zürich, Zurich |
| Debeka | - |
| Dongguan Ione Electronic | China, Dongguang, Guangdong |
| Fifth Third Capital | Cincinnati, Ohio, United States |
| Frumtak Ventures | Gullbringusysla, Iceland, Reykjavík |
| JIG-SAW | Chiyoda, Japan |
| Jinyuan Development Company | - |
| Kupanda Capital | District of Columbia, United States, Washington |
| Multi-Act | - |
| PDL Biopharma | Incline Village, Nevada, United States |
| SUSI Partners | Switzerland, Zug, Zug |
| Tarena | Beijing, Beijing, China |
| Tugboat | - |
| Virtual Network SA | Nyon, Switzerland, Vaud |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data 